Tomasz Krzysztof Jaskólski
age 53Currently 11 roles in 6 KRS entities. In the KRS since 2010.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Fenix-Fund sp. z o.o. |
since Dec 16, 2013 | Dec 16, 2013 | Królowej Jadwigi 16, 85-231 Bydgoszcz |
Medyczne Innowacje Diagnostyczne Mid sp. z o.o. |
since Nov 7, 2017 | Nov 7, 2017 | ul. Gen. Józefa Hallera 2E, 85-795 Bydgoszcz |
Niepubliczny Zakład Opieki Zdrowotnej Awimed sp. z o.o. |
since Feb 19, 2010 | Feb 19, 2010 | Gen. J. Hallera 2/C, 85-795 Bydgoszcz |
Syto Event sp. z o.o. |
since Jan 17, 2023 | Jan 17, 2023 | ul. Leśna 1, 86-060 Prądocin |
since Aug 30, 2011 | Aug 30, 2011 | Hallera 2 C, 85-795 Bydgoszcz |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Business resumed | Liquidator, Partner Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | |
| Role changed | President of the Management Board → Liquidator Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | |
| Liquidation opened | Liquidator, President of the Management Board, Partner. Resolution No. 3 of the extraordinary meeting of shareholders dated 11 December 2024, drawn up in the minutes of the company's extraordinary meeting of shareholders by notary Michał Gutmański, notary office at ul. Pod Blankami 39-45/4 in Bydgoszcz, repertory A 7209/2024, 11 December 2024. Liquidator: Tomasz Krzysztof Jaskólski. Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | |
| Share capital increased | Share capital: PLN 354,000 → PLN 420,000. Partner: 12.15% of shares worth PLN 43,000 → 12.14% of shares worth PLN 51,000 Vitalabo Diag Invest sp. z o.o. | Vitalabo Diag Invest sp. z o.o. | |
| Appointed | Deputy Director of the Management Board Fenix-Fund sp. z o.o. | Fenix-Fund sp. z o.o. | |
| Share capital increased | Share capital: PLN 280,000 → PLN 354,000. Partner: 34 shares worth PLN 34,000 → 12.15% of shares worth PLN 43,000 Vitalabo Diag Invest sp. z o.o. | Vitalabo Diag Invest sp. z o.o. | |
| Share capital increased | Share capital: PLN 140,000 → PLN 280,000. Partner: 17 shares worth PLN 17,000 → 34 shares worth PLN 34,000 Vitalabo Diag Invest sp. z o.o. | Vitalabo Diag Invest sp. z o.o. | |
| Company founded | President of the Management Board, Partner (50% of shares worth PLN 3,000) Syto Event sp. z o.o. | Syto Event sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation |
|
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Anna Pietrykowskaage 50 | since Dec 16, 2013 | ||
Mateusz Adam Maciejewskiage 39 | Fenix-Fund sp. z o.o. | since Mar 14, 2024 | |
Szymon Stanisław Kopaage 42 | Fenix-Fund sp. z o.o. | since Dec 16, 2013 | |
Sylwia Łucja Jaskólskaage 53 | since Jan 17, 2023 | ||
Filip Jakub Sikoraage 47 | Medyczne Innowacje Diagnostyczne Mid sp. z o.o. | since Nov 7, 2017 |